Pharmacokinetics of florfenicol in serum and synovial fluid after regional intravenous perfusion in the distal portion of the hind limb of adult cows

American Journal of Veterinary Research

Volumn 69, Issue 8, 2008, Pages 997-1004

  Gilliam, John N ^a   Streeter, Robert N ^a   Papich, Mark G ^c   Washburn, Kevin E ^d   Payton, Mark E ^b  

^a OKLAHOMA STATE UNIVERSITY   (United States)

^b 301 MSCS   (United States)

^c NORTH CAROLINA STATE UNIVERSITY   (United States)

^d TEXAS A AND M UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLORFENICOL;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; COW; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG HALF LIFE; DRUG SYNOVIAL FLUID LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTRAVENOUS CATHETER; MAXIMUM PLASMA CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PLASMA CONCENTRATION-TIME CURVE; REGIONAL PERFUSION; TIME TO MAXIMUM PLASMA CONCENTRATION;

ANIMALS; ANTI-BACTERIAL AGENTS; AREA UNDER CURVE; CATTLE; FEMALE; HINDLIMB; INFUSIONS, INTRAVENOUS; PERFUSION; SYNOVIAL FLUID; THIAMPHENICOL;

BOS;

EID: 49749099246     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.69.8.997     Document Type: Article

References (63)

1. Hernandez JA, Garbarino EJ, Shearer JK, et al. Comparison of the calving-to-conception interval in dairy cows with different degrees of lameness during the prebreeding postpartum period. J Am Vet Med Assoc 2005;227:1284-1291.
2. Melendez P, Bartolome J, Archbald LF, et al. The association between lameness, ovarian cysts, and fertility in lactating dairy cows. Theriogenology 2003;59:927-937.
3. Garbarino EJ, Hernandez JA, Sweeper JK, et al. Effect of lameness on ovarian activity in postpartum holstein cows. J Dairy Sci 2004;87:4123-4131.
4. Sogstad AM, Osteras O, Fjeldaas T. Bovine claw and limb disorders related to reproductive performance and production diseases. J Dairy Sci 2006;89:2519-2528.
5. Hernandez JA, Garbarino EJ, Shearer JK, et al. Comparison of milk yield in dairy cows with different degrees of lameness. J Am Vet Med Assoc 2005;227:1292-1296.
6. Green LE, Hedges VJ, Schukken YH, et al. The impact of clinical lameness on the milk yield of dairy cows. J Dairy Sci 2002;85:2250-2256.
7. Booth CJ, Warnick LD, Grohn YT, et al. Effect of lameness on culling in dairy cows. J Dairy Sci 2004;87:4115-4122.
8. Whay HR. Pain in the lame cow. Cattle Pract 1997;5:113-118.
9. Singh GR, Amarpal, Aithal HP, et al. Lameness in cattle - a review. Indian J Anim Sci 2005;75:723-740.
10. Trent AM, Plumb D. Treatment of infectious arthritis and osteomyelitis. Vet Clin North Am Food Anim Pract 1991;7:747-778.
11. Orsini JA. Strategies for treatment of bone and joint infections in large animals. J Am Vet Med Assoc 1984;185:1190-1193.
12. Jackson PGG, Strachan WD, Tucker AW et al. Treatment of septic arthritis in calves by joint lavage: a study of 20 cases. Ir Vet J 1999;52:563-569.
13. Tulleners EP. Management of bovine orthopedic problems. Part ii. Coxofemoral luxations, soft tissue problems, sepsis, and miscellaneous skull problems. Compend Contin Educ Pract Vet 1986;8:S117-S125.
14. Smith JA, Williams RJ, Knight AP. Drug therapy for arthritis in food-producing animals. Compend Contin Educ Pract Vet 1989;11:87-93.
15. Lazzarini L, Lipsky BA, Mader JT. Antibiotic treatment of osteomyelitis: what have we learned from 30 years of clinical trials? Int J Infect Dis 2005;9:127-138.
16. Lazzarini L, Mader JT, Calhoun JH. Osteomyelitis in long bones. J Bone Joint Surg Am 2004;86:2305-2318.
17. Goodrich LR, Nixon AJ. Treatment options for osteomyelitis. Equine Vet Educ 2004;16:267-280.
18. Guard C. Strategies for managing septic arthritis of the digit in cattle, in Proceedings. 33rd Annu Conf Am Assoc Bov Pract 2000;21-23.
19. Hau T, Nishikawa RA, Phuangsab A. The effect of bacterial trapping by fibrin on the efficacy of systemic antibiotics in experimental peritonitis. Surg Gynecol Obstet 1983;157:252-256.
20. Johnson KA. Osteomyelitis in dogs and cats. J Am Vet Med Assoc 1994;205:1882-1887.
21. Henry SL, Galloway KP. Local antimicrobial therapy for the management of orthopedic infections. Clin Pharmacokinet 1995;29:36-45.
22. Rochat MC. Preventing and treating osteomyelitis. Vet Med (Praha) 2001;96:678-685.
23. Whitehair KJ, Adams SB, Parker JE, et al. Regional limb perfusion with antibiotics in three horses. Vet Surg 1992;21:286-292.
24. Whitehair KJ, Bowerstock TL, Blevins WE, et al. Regional limb perfusion for antibiotic treatment of experimentally induced septic arthritis. Vet Surg 1992;21:367-373.
25. Murphey ED, Santschi EM, Papich MG. Regional intravenous perfusion of the distal limb of horses with amikacin sulfate. J Vet Pharmacol Ther 1999;22:68-71.
26. Werner LA, Hardy J, Bertone AL. Bone gentamicin concentration after intra-articular or regional intravenous perfusion in the horse. Vet Surg 2003;32:559-565.
27. Pille F, Baere SD, Ceelen L, et al. Synovial fluid and plasma concentrations of ceftiofur after regional intravenous perfusion in the horse. Vet Surg 2005;34:610-617.
28. Rubio-Martinez LM, Lopez-Sanroman J, Cruz AM, et al. Evaluation of safety and pharmacokinetics of vancomycin after intravenous regional limb perfusion in horses. Am J Vet Res 2005;66:2107-2113.
29. Parra-Sanchez A, Lugo J, Boothe DM, et al. Pharmacokinetics and pharmacodynamics of enrofloxacin and a low dose of amikacin administered via regional intravenous limb perfusion in standing horses. Am J Vet Res 2006;67:1687-1695.
30. Gehring R, Haskell SR, Payne MA, et al. Aminoglycoside residues in food of animal origin. J Am Vet Med Assoc 2005;227:63-66.
31. FARAD. Prohibited Drug List. Available at: www.farad.org/prohibit.html. Accessed Mar 15, 2007.
32. Gagnon H, Ferguson JG, Papich MG, et al. Single-dose pharmacokinetics of cefazolin in bovine synovial fluid after intravenous regional injection. J Vet Pharmacol Ther 1994;17:31-37.
33. Navarre CB, Zhang L, Sunkara G, et al. Ceftiofur distribution in plasma and joint fluid following regional limb injection in cattle. J Vet Pharmacol Ther 1999;22:13-19.
34. Dietz O, Gangel H, Woborill J. Intravenous local antibiotic treatment for infectious diseases of the hoof and claw in cattle. Monatsh Veterinarmed 1980;35:729-734.
35. Steiner A, Ossent P, Mathis GA. intravenous regional anaesthesia and antibiotic therapy applied to the limbs of cattle: indications, techniques and complications. Schweiz Arch Tierheilkd 1990;132:227-237.
36. Rubio-Martinez L, Cruz AM. Antimicrobial regional limb perfusion in horses. J Am Vet Med Assoc 2006;228:706-712.
37. Fajt VR, Apley MD. Antimicrobial issues in bovine lameness. Vet Clin North Am Food Anim Pract 2001;17:159-173.
38. deHaas V, Bonnier M, Gicquel M, et al. Florfenicol: a time- or concentration-dependent antibiotic. XXII World Buiatrics Congress 2002;17-25.
39. Nuflor Injectable Solution product information. Available at: www.nuflor.com/_pdfs/productdisclosure.pdf. Accessed Mar 15, 2007.
40. deCraene BA, Deprez P, D'Haese E, et al. Pharmacokinetics of florfenicol in cerebrospinal fluid and plasma of calves. Antimicrob Agents Chemother 1997;41:1991-1995.
41. Bretzlaff KN, Neff-Davis CA, Ott RS, et al. Florfenicol in non-lactating dairy cows: pharmacokinetics, binding to plasma proteins, and effects on phagocytosis by blood neutrophils. J Vet Pharmacol Ther 1987;10:233-240.
42. Soback S, Paape MJ, Filep R, et al. Florfenicol pharmacokinetics in lactating cows after intravenous, intramuscular and intramammary administration. J Vet Pharmacol Ther 1995;18:413-417.
43. Adams PE, Varma KJ, Powers TE, et al. Tissue concentrations and pharmacokinetics of florfenicol in male veal calves given repeated doses. Am J Vet Res 1987;48:1725-1732.
44. Varma KJ, Adams PE, Powers TE, et al. Pharmacokinetics of florfenicol in veal calves. J Vet Pharmacol Ther 1986;9:412-425.
45. Lobell RD, Varma KJ, Johnson JC, et al. Pharmacokinetics of florfenicol following intravenous and intramuscular doses to cattle. J Vet Pharmacol Ther 1994;17:253-258.
46. The United States Pharmacopeia. Rockville, Md: US Pharmacopeial Convention, 2006.
47. Gibaldi M, Perrier B. Pharmacokinetics. 2nd ed. New York: Marcel-Dekker, 1982.
48. Gabrielsson J, Weiner D. Pharmacokinetic and pharmacodynamic data analysis, concepts and applications. 3rd ed. Stockholm: Swedish Pharmaceutical Press, 2001.
49. Hurley JD, Wilson SD, Worman LM, et al. Chronic osteomyelitis. Treatment by regional perfusion with antibiotics. Arch Surg 1966;92:548-553.
50. Finsterbush A, Weinberg H. Venous perfusion of the limb with antibiotics for osteomyelitis and other chronic infections. J Bone Joint Surg Am 1972;54:1227-1234.
51. Nuflor Injectable Solution Environmental Assessment. Available at: www.fda.gov/cvm/FOI/141-063EA.pdf. Accessed Jun 1, 2007.
52. El-Aty AM, Goudah A, El-Sooud KA, et al. Pharmacokinetics and bioavailability of florfenicol following intravenous, intramuscular and oral administrations in rabbits. Vet Res Commun 2004;28:515-524.
53. Park BK, Lim JH, Kim MS, et al. Pharmacokinetics of florfenicol and its major metabolite, florfenicol amine, in rabbits. J Vet Pharmacol Ther 2007;30:32-36.
54. Senoh H, Aiso S, Arito H, et al. Carcinogenicity and chronic toxicity after inhalation exposure of rats and mice to N,N-dimethylformamide. J Occup Health 2004;46:429-439.
55. Fail PA, George JD, Grizzle TB, et al. Formamide and dimethylformamide: reproductive assessment by continuous breeding in mice. Reprod Toxicol 1998;12:317-332.
56. Kowalski P, Konieczna L, Chmielewska A, et al. Comparative evaluation between capillary electrophoresis and high-performance liquid chromatography for the analysis of florfenicol in plasma. J Pharm Biomed Anal 2005;39:983-989.
57. Nagaraja TG, Narayanan SK, Stewart GC, et al. Fusobacterium necrophorum infections in animals: pathogenesis and pathogenic mechanisms. Anaerobe 2005;11:239-246.
58. Verschooten F, Vermeiren D, Devriese L. Bone infection in the bovine appendicular skeleton: a clinical, radiographic, and experimental study Vet Radiol Ultrasound 2000;41:250-260.
59. Freedom of Information Summary. NADA 141-063, Nuflor Injectable Solution, 1999, Available at: www.fda.gov/ohrms/dockets/98fr/ 141063Fi.pdf. Accessed Jun 1, 2007.
60. Yoshimura H, Kojima A, Ishimaru M. Antimicrobial susceptibility of Arcanobacterium pyogenes isolated from cattle and pigs. J Vet Med B Infect Dis Vet Public Health 2000;47:139-143.
61. Chirino-Trejo M, Woodbury MR, Huang F. Antibiotic sensitivity and biochemical characterization of Fusobacterium spp. and Arcanobacterium pyogenes isolated from farmed white-tailed deer ( Odocoileus virginianus) with necrobacillosis. J Zoo Wildl Med 2003;34:262-268.
62. Gagea MI, Bateman KG, Shanahan RA, et al. Naturally occurring Mycoplasma bovis-associated pneumonia and polyarthritis in feedlot beef calves. J Vet Diagn Invest 2006;18:29-40.
63. Ayling RD, Baker SE, Peek ML, et al. Comparison of in vitro activity of danofloxacin, florfenicol, oxytetracycline, spectinomycin and tilmicosin and recent field isolates of Mycoplasma bovis. Vet Rec 2000;146:745-747.